MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2

Cancer Letters

Volumn 329, Issue 1, 2013, Pages 84-90

  Li, Juan ^a   Du, Lutao ^a   Yang, Yongmei ^a   Wang, Chuanxin ^a   Liu, Hui ^a   Wang, Lili ^a   Zhang, Xin ^a   Li, Wei ^a   Zheng, Guixi ^a   Dong, Zhaogang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; MiR 429; Prognosis; SOX2

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 145; MICRORNA 429; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RECTUM CARCINOMA; SEQUENCE ANALYSIS; TUMOR VOLUME; UPREGULATION;

APOPTOSIS; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; SOXB1 TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871716110     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.10.019     Document Type: Article

References (27)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
3. Schickel R., Boyerinas B., Park S.M., Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27:5959-5974.
4. Heneghan H.M., Miller N., Kerin M.J. MiRNAs as biomarkers and therapeutic targets in cancer. Curr. Opin. Pharmacol. 2010, 10:543-550.
5. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
6. Zhao P., Dai M., Chen W., Li N. Cancer trends in China. Jpn. J. Clin. Oncol. 2010, 40:281-285.
7. Schetter A.J., Okayama H., Harris C.C. The role of microRNAs in colorectal cancer. Cancer J. 2012, 18:244-252.
8. Sun T., Wang C., Xing J., Wu D. MiR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur. J. Cancer 2011, 47:2552-2559.
9. Uhlmann S., Zhang J.D., Schwager A., Mannsperger H., Riazalhosseini Y., Burmester S., Ward A., Korf U., Wiemann S., Sahin O. MiR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 2010, 29:4297-4306.
10. Snowdon J., Zhang X., Childs T., Tron V.A., Feilotter H. The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One 2011, 6:e22828.
11. Han Y., Chen J., Zhao X., Liang C., Wang Y., Sun L., Jiang Z., Zhang Z., Yang R., Chen J., Li Z., Tang A., Li X., Ye J., Guan Z., Gui Y., Cai Z. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011, 6:e18286.
12. Nam E.J., Yoon H., Kim S.W., Kim H., Kim Y.T., Kim J.H., Kim J.W., Kim S. MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 2008, 14:2690-2695.
13. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
14. Otsubo T., Akiyama Y., Hashimoto Y., Shimada S., Goto K., Yuasa Y. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 2011, 6:e16617.
15. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
16. Mees S.T., Mardin W.A., Wendel C., Baeumer N., Willscher E., Senninger N., Schleicher C., Colombo-Benkmann M., Haier J. EP300-a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer 2010, 126:114-124.
17. Lee J.W., Park Y.A., Choi J.J., Lee Y.Y., Kim C.J., Choi C., Kim T.J., Lee N.W., Kim B.G., Bae D.S. The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol. Oncol. 2011, 120:56-62.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
19. West N.J., Courtney E.D., Poullis A.P., Leicester R.J. Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1680-1687.
20. Luthi A.U., Martin S.J. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 2007, 14:641-650.
21. Timmer J.C., Salvesen G.S. Caspase substrates. Cell Death Differ. 2007, 14:66-72.
22. Wu W.K., Law P.T., Lee C.W., Cho C.H., Fan D., Wu K., Yu J., Sung J.J. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011, 32:247-253.
23. Nie J., Liu L., Zheng W., Chen L., Wu X., Xu Y., Du X., Han W. MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis 2012, 33:220-225.
24. Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W., Orkin S.H. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
25. Hu Q., Zhang L., Wen J., Wang S., Li M., Feng R., Yang X., Li L. The EGF receptor-SOX2-EGF receptor feedback loop positively regulates the self-renewal of neural precursor cells. Stem Cells 2010, 28:279-286.
26. Otsubo T., Akiyama Y., Yanagihara K., Yuasa Y. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br. J. Cancer 2008, 98:824-831.
27. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. MiRNAs in human cancer. J. Pathol. 2011, 223:102-115.